Beijing-based mobile healthcare app maker Spring Rain Software Co. Ltd. says it has completed US$50 million series C financing from China International Capital Corporation Limited (CICC), Rushan Investment Management and Pavilion Capital, according to a company announcement.
Existing investor BlueRun Ventures also participated in the round.
Founded in 2011, Spring Rain Software, also known as Chunyu Yisheng, received US$3 million series A financing from BlueRun Ventures in 2011, and received US$8 million series B financing from BlueRun Ventures and others the next year.
The proceeds from the latest round will be used to expand the app’s user base and increase the numbers of doctors on the app, as well as further monetize the app through cooperation with hospitals, pharmaceuticals companies, drug stores, insurance companies, and wearable device makers.
As the developer of Spring Rain Palm Doctor, Spring Rain Palm has three million registered users, with 40,000 registered doctors on the platform and 50,000 health tips provided daily on the app.